Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium. Bautista, F.; Moreno, L.; Marshall, L.; Pearson, A. D. J.; Geoerger, B.; Paoletti, X.. Eur J Cancer. 2017; 275-284: p.275-284. doi:10.1016/j.ejca.2017.09.015 10.1016/j.ejca.2017.09.015. Epub 2017 Oct 19.Article
Oncostat